RedHill Biopharma (RDHL) Shares Outstanding (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Shares Outstanding (Entity) of $3.2 billion for Q4 2025, up 156.37% year-over-year from $1.2 billion in Q4 2024, and up 75.22% quarter-over-quarter from $1.8 billion in Q2 2025.
RedHill Biopharma (RDHL) Shares Outstanding (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Shares Outstanding (Entity) for 15 consecutive years, with $3.2 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 156.37% year-over-year to $3.2 billion; the TTM figure through Dec 2025 stood at $3.2 billion (up 156.37% YoY), while the FY2025 annual figure was $3.2 billion, up 156.37% from the prior year.
- Shares Outstanding (Entity) improved to $3.2 billion in Q4 2025 per RDHL's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $3.2 billion in Q4 2025 and bottomed at $11380.0 in Q1 2023.
- Historically, Shares Outstanding (Entity) has averaged $615.7 million across 5 years, with a median of $3.8 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 21.75% — and 2024, when it soared 22906.83%.
- RedHill Biopharma's Shares Outstanding (Entity) stood at $46527.0 in 2021, then soared by 5224.21% to $2.5 million in 2022, then surged by 318.41% to $10.4 million in 2023, then jumped by 11788.91% to $1.2 billion in 2024, then soared by 156.37% to $3.2 billion in 2025.
- Business Quant data shows RDHL's Shares Outstanding (Entity) at $3.2 billion in Q4 2025, $1.8 billion in Q2 2025, and $1.2 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 3.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.59 Bn |
| Jun 30, 2025 | 18.03 Bn |
| Dec 31, 2024 | 12.32 Bn |
| Jun 30, 2024 | 11.76 Bn |
| Dec 31, 2023 | 103.65 Mn |
| Jun 30, 2023 | 51.12 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 24.77 Mn |
| Sep 30, 2022 | 568,308.00 |
| Jun 30, 2022 | 568,308.00 |
| Mar 31, 2022 | 2.00 |
| Dec 31, 2021 | 465,273.00 |
| Sep 30, 2021 | 467,908.00 |
| Jun 30, 2021 | 466,801.00 |
| Mar 31, 2021 | 364,276.00 |
| Dec 31, 2020 | 364,276.00 |
| Sep 30, 2020 | 372,893.00 |
| Jun 30, 2020 | 357,668.00 |
| Mar 31, 2020 | 296,922.00 |
| Dec 31, 2019 | 296,922.00 |